Evaluation of different techniques in the diagnosis of Toxoplasma encephalitis

Journal of Medical Microbiology

Volumn 46, Issue 7, 1997, Pages 597-601

  Rodriguez J C ^a   Martinez M M ^b   Martinez A R ^b   Royo, G ^a  

^a HOSPITAL GENERAL UNIVERSITARIO DE ELCHE   (Spain)

^b UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; PROTOZOAL DNA; PROTOZOON ANTIBODY;

ANTIBODY DETECTION; ANTIGEN DETECTION; ARTICLE; CEREBROSPINAL FLUID ANALYSIS; CHEMOLUMINESCENCE; CONTROLLED STUDY; ENCEPHALITIS; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SERUM; TOXOPLASMA; TOXOPLASMOSIS;

EID: 0030791492     PISSN: 00222615     EISSN: None     Source Type: Journal    
DOI: 10.1099/00222615-46-7-597     Document Type: Article

References (35)

1. Luft BJ, Remington JS. Toxoplasmic encephalitis in AIDS. Clin Infect Dis 1992; 15: 211-222.
2. Wong SY, Israelski DM, Remington JS. AIDS-associated toxoplasmosis. In: Sande MA, Volverding PA (eds) The medical management of AIDS, 4th edn. Philadelphia, WB Sanders. 1995; 460-493.
3. Zangerle R, Allerberger F, Pohl P, Fritsch P, Dierich MP. High risk of developing toxoplasmic encephalitis in AIDS patients seropositive to Toxoplasma gondii. Med Microbiol Immunol 1991; 180: 59-66.
4. Porter SB, Sande MA. Toxoplasmosis of the central nervous system in the acquired immunodeficiency syndrome. N Engl J Med 1992; 327: 1643-1648.
5. Joynson DHM, Payne RA, Balfour AH, Prestage ES, Fleck DG. Five commercial enzyme linked immunosorbent assay kits for toxoplasma specific IgM antibody. J Clin Pathol 1989; 42: 653-657.
6. Wilson M, Ware DA, Walls KW. Evaluation of commercial serodiagnostic kits for toxoplasmosis. J Clin Microbiol 1987; 25: 2262-2265.
7. Verhofstede C, Van Renterghem L, Plum J. Comparison of six commercial enzyme linked immunosorbent assays for detecting IgM antibodies against Toxoplasma gondii. J Clin Pathol 1989; 42: 1285-1290.
8. Del Bono V, Canessa A, Bruzzi P, Fiorelli MA, Terragna A. Significance of specific immunoglobuhn M in the chronological diagnosis of 38 cases of toxoplasmic lymphadenopathy. J Clin Microbiol 1989; 27: 2133-2135.
9. Holliman RE, Raymond R, Renton N, Johnson JD. The diagnosis of toxoplasmosis using IgG avidity. Epidemiol Infect 1994; 112: 399-408.
10. Lappalainen M, Koskela P, Koskiniemi M, et al. Toxoplasmosis acquired during pregnancy: improved serodiagnosis based on avidity of IgG. J Infect Dis 1993; 167: 691-697.
11. Hoshino-Shimizu S, Mineo JR, Camargo MA. Lectin used in the purification process of Toxoplasma gondii tachyzoites. J Parasitol 1980; 66: 989-991.
12. Sambrook J, Fritsch EF, Maniatis T (eds). Molecular cloning - a laboratory manual, 2nd edn. Cold Spring Harbor, NY Cold Spring Harbor Laboratory Press. 1989: 12-13.
13. van Knapen F, Panggabean SO, van Leusden J. Evaluation of laboratory diagnosis of toxoplasmosis by means of an ELISA-triple test. Detection of class specific IgG, IgM and circulating antigens. Anlońie van Leeitwenhoek 1986; 52: 5-13.
14. Turunen HJ. Detection of soluble antigens of Toxoplasma gondii by a four-layer modification of an enzyme immunoassay. J Clin Microbiol 1983; 17: 768-773.
15. Lindenschmidt EG. Enzyme-linked inmunosorbent assay for detection of soluble Toxoplasma gondii antigen in acute-phase toxoplasmosis. Eur J Clin Microbiol 1985; 4: 488-492.
16. Burg JL, Grover CM, Pouletty P, Boothroyd JC. Direct and sensitive detection of a pathogenic protozoan, Toxoplasma gondii, by polymerase chain reaction. J Clin Microbiol 1989; 27: 1787-1792.
17. Malloy D, Nauman RK, Paxton H. Detection of Borrelia burgdorferi using the polymerase chain reaction. J Clin Microbiol 1990; 28: 1089-1093.
18. Derouin F, Thulliez P, Garin YJ. [Value and limitations of toxoplasmosis serology in HIV patients.] Pathol Biologie (Paris) 1991; 39: 255-259.
19. Zufferey J, Sugar A, Rudaz P, Bille J, Glauser MP, Chave JP. Prevalence of latent toxoplasmosis and serological diagnosis of active infection in HIV-positive patients. Eur J Microbiol Infect Dis 1993; 12: 591-595.
20. Jaqueti J, Nicolas D, Navarro Gallar F. [Persistence of IgA antibodies against Toxoplasma gondii with ELISA.] Med Clin (Barcelona) 1994; 103: 197.
21. Patel B, Young Y, Duffy K, Tanner RP, Johnson J, Holliman RE. Immunoglobulin-A detection and the investigation of clinical toxoplasmosis. J Med Microbiol 1993; 38: 286-292.
22. Pinon JM, Foudrinier F, Mougeot G et al. Evaluation of risk and diagnostic value of quantitative assays of anti-Toxoplasma gondii immunoglobulin A (IgA), IgE, and IgM and analytical study of specific IgG in immunodeficient patients. J Clin Microbiol 1995; 33: 878-884.
23. Holliman RE. Serological study of the prevalence of toxoplasmosis in asymptomatic patients infected with human immunodeficiency virus. Epidemiol Infect 1990; 105: 415-418.
24. Grant IH, Gold JWM, Rosenblum M, Niedzwiecki D, Armstrong D. Toxoplasma gondii serology in HIV-infected patients: the development of central nervous system toxoplasmosis in AIDS. AIDS 1990; 4: 519-521.
25. Dannemann BR, Israelski DM, Leoung GS, McGraw T, Mills J, Remington JS. Toxoplasma serology, parasitemia and antigenemia in patients at risk for toxoplasmic encephalitis. AIDS 1991; 5: 1363-1365.
26. Hassl A, Aspock H, Flamm H. Circulating antigen of Toxoplasma gondii in patients with AIDS: significance of detection and structural properties. Zentralbl Bakteriol Mikrobiol Hyg A 1988; 270: 302-329.
27. Candolfi E, Derouin F, Kien T. Detection of circulating antigens in immunocompromised patients during reactivation of chronic toxoplasmosis. Eur J Clin Microbiol 1987; 6: 44-48.
28. Letillois MF, Laigle V, Santoro F, Micoud M, Chumpitazi BFF Toxoplasma gondii surface antigen-1 in sera of HIV-infected patients as an indicator of reactivated toxoplasmosis. Eur J Clin Microbiol Infect Dis 1995; 14: 899-903.
29. Wastling JM, Nicoll S, Buxton D. Comparison of two gene amplification methods for the detection of Toxoplasma gondii in experimentally infected sheep. J Med Microbiol 1993; 38: 360-365.
30. Gross U, Roggenkamp A, Janitschke K, Heesemann J. Improved sensitivity of the polymerase chain reaction for detection of Toxoplasma gondii in biological and human clinical specimens. Eur J Clin Microbiol Infect Dis 1992; 11: 33-39.
31. Cristina N, Pelloux H, Goulhot C, Brion JP, Leclercq P, Ambroise Thomas PTI. Detection of Toxoplasma gondii in AIDS patients by the polymerase chain reaction. Infection 1993; 21: 150-153.
32. Østergaard L, Nielsen AK, Black FT. DNA amplification on cerebrospinal fluid for diagnosis of cerebral toxoplasmosis among HIV-positive patients with signs or symptoms of neurological disease. Scand J Infect Dis 1993; 25: 227-237.
33. Schoondermark-van de Ven E, Galama J, Kraaijeveld C, van Druten J, Meuwissen J, Melchers W. Value of the polymerase chain reaction for the detection of Toxoplasma gondii in cerebrospinal fluid from patients with AIDS. Clin Infect Dis 1993; 16: 661-666.
34. Lebech M, Lebech A-M, Nelsing S, Vuust J, Malinesen J, Petersen E. Detection of Toxoplasma gondii DNA by polymerase chain reaction in cerebrospinal fluid from AIDS patients with cerebral toxoplasmosis. J Infect Dis 1992; 165: 982-983.
35. Novati R, Castagna A, Morsica G et al. Polymerase chain reaction for Toxoplasma gondii DNA in the cerebrospinal fluid of AIDS patients with focal brain lesions. AIDS 1994; 8: 1691-1694.